About
Neuboron Medical Group (NMG) was founded in 2014 in Nanjing and then expanded to Xiamen in China. The Neuboron is the first company in China focused on providing Boron Neutron Capture Therapy (BNCT) total solution to hospital users, including hardware, software, and boron drugs. The Neuboron is an R&D oriented enterprise that has built a completed and comprehensive know-how and capability over the whole BNCT technology. Neuboron has installed its first compact AB-BNCT system, NeuPex (Block-I), and has successfully performed its investigator-initiated trial (IIT) on patients at the Xiamen Humanity Hospital (XHH) BNCT Center in 2022.
Technologies
Apache
Mobile Friendly
Baidu Ads
Google Tag Manager
Keywords
medical equipment manufacturing
oncology
patient positioning system
targeted therapy
treatment center
neutron source
mri-detectable boron nanoparticles
medical technology
medical device design
cancer therapy
monte carlo engine
cyclotron bnct
boron drugs
targeted heavy-ion therapy
cancer treatment
healthcare technology
boron carrier development
medical device
treatment planning
radiobiology of bnct
clinical research
b2b
clinical trial bnct
cyclotron-based neutron source
government
clinical bnct
bnct
neuboron neupex
neutron therapy for glioma
boron neutron capture therapy
Company Information
-
Employees 4
-
Founded 2014
-
Total Funding $10000000
Location
Nanjing, Jiangsu, China
